ConductScience.org, home

Paper29708331

Effects of the 1- N-(4-Amino-2 S-hydroxybutyryl) and 6'- N-(2-Hydroxyethyl) Substituents on Ribosomal Selectivity, Cochleotoxicity, and Antibacterial Activity in the Sisomicin Class of Aminoglycoside Antibiotics.

Sonousi A and 6 others. ACS Infect Dis, 2018. Cited by 22 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of the 1- N-(4-Amino-2 S-hydroxybutyryl) and 6'- N-(2-Hydroxyethyl) Substituents on Ribosomal Selectivity, Cochleotoxicity, and Antibacterial Activity in the Sisomicin Class of Aminoglycoside Antibiotics. Papers, record 29708331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29708331

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of the 1- N-(4-Amino-2 S-hydroxybutyryl) and 6'- N-(2-Hydroxyethyl) Substituents on Ribosomal Selectivity, Cochleotoxicity, and Antibacterial Activity in the Sisomicin Class of Aminoglycoside Antibiotics.
PubMed
Journal
ACS Infect Dis
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.04
iCite
Revised in PubMed
2020-03-06
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sonousi AAmr
2Sarpe VAVikram A
3Brilkova MMargarita
4Schacht JJochen
5Vasella AAndrea
6Böttger ECErik C
7Crich DDavidhttps://orcid.org/0000-0003-2400-0083

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoglycosidesMajor topic
Anti-Bacterial AgentsMajor topic
RibosomesMajor topic
SisomicinMajor topic
Base Sequence
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Escherichia coli
Humans
Microbial Sensitivity Tests
Protein Biosynthesis
Structure-Activity Relationship

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI123352NIAID NIH HHSUnited StatesR01AI123352PubMed and NIH

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126,877,861Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.Medchemcomm2016https://conductscience.org/library/papers/26877861PubMed
222,699,498Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22699498PubMed
325,209,664Structural basis for the inhibition of the eukaryotic ribosome.Nature2014https://conductscience.org/library/papers/25209664PubMed
44,143,427Structures and syntheses of aminoglycoside antibiotics.Adv Carbohydr Chem Biochem1974https://conductscience.org/library/papers/4143427PubMed
528,343,384N6', N6''', and O4' Modifications to Neomycin Affect Ribosomal Selectivity without Compromising Antibacterial Activity.ACS Infect Dis2017https://conductscience.org/library/papers/28343384PubMed
626,294,060Selective Protection of Secondary Amines as the N-Phenyltriazenes. Application to Aminoglycoside Antibiotics.Org Lett2015https://conductscience.org/library/papers/26294060PubMed
727,746,889Endless Resistance. Endless Antibiotics?Medchemcomm2016https://conductscience.org/library/papers/27746889PubMed
827,745,736Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae.Diagn Microbiol Infect Dis2016https://conductscience.org/library/papers/27745736PubMed
926,024,064Influence of 4'-O-Glycoside Constitution and Configuration on Ribosomal Selectivity of Paromomycin.J Am Chem Soc2015https://conductscience.org/library/papers/26024064PubMed
1029,385,736Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors.Molecules2018https://conductscience.org/library/papers/29385736PubMed
1125,837,512Ribosome. The complete structure of the 55S mammalian mitochondrial ribosome.Science2015https://conductscience.org/library/papers/25837512PubMed
12413,921Semisynthetic aminoglycoside antibacterials. 6. Synthesis of sisomicin, Antibiotic G-52, and novel 6'-substituted analogues of sisomicin from aminoglycoside 66-40C.J Med Chem1978https://conductscience.org/library/papers/413921PubMed
1321,282,439In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21282439PubMed
144,609,627The use of N-hydroxy-5-morbornene-2,3-dicarboximide active esters in peptide synthesis.Chem Pharm Bull (Tokyo)1974https://conductscience.org/library/papers/4609627PubMed
1511,667,239Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1).J Org Chem1996https://conductscience.org/library/papers/11667239PubMed
1622,512,755Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.Expert Rev Anti Infect Ther2012https://conductscience.org/library/papers/22512755PubMed
1724,990,531The evolving role of chemical synthesis in antibacterial drug discovery.Angew Chem Int Ed Engl2014https://conductscience.org/library/papers/24990531PubMed
1824,038,605Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.Angew Chem Int Ed Engl2013https://conductscience.org/library/papers/24038605PubMed
1920,805,391Synthesis and spectrum of the neoglycoside ACHN-490.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20805391PubMed
2017,766,247Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria.Nucleic Acids Res2007https://conductscience.org/library/papers/17766247PubMed

See all 47 references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
41,755,818G1405 Ribosomal Methyltransferase-Driven Antibacterial Resistance Affects the 4,5-Disubstituted-2-deoxystreptamine Class of Aminoglycoside Antibiotics.JACS Au2026https://conductscience.org/library/papers/41755818PubMed
41,383,247Plazomicin: A promising novel antimicrobial in the era of bacterial resistance (Review).Exp Ther Med2026https://conductscience.org/library/papers/41383247PubMed
40,384,761Strategic re-engineering of antibiotics.Nat Rev Bioeng2025https://conductscience.org/library/papers/40384761PubMed
39,211,618Decarboxylation in Natural Products Biosynthesis.JACS Au2024https://conductscience.org/library/papers/39211618PubMed
36,544,494Facile and selective N-alkylation of gentamicin antibiotics via chemoenzymatic synthesis.Green Chem2022https://conductscience.org/library/papers/36544494PubMed
34,117,352Structural basis for plazomicin antibiotic action and resistance.Commun Biol2021https://conductscience.org/library/papers/34117352PubMed
34,114,793Synthesis and Antibacterial Activity of Propylamycin Derivatives Functionalized at the 5''- and Other Positions with a View to Overcoming Resistance Due to Aminoglycoside Modifying Enzymes.ACS Infect Dis2021https://conductscience.org/library/papers/34114793PubMed
34,078,922Structural and phylogenetic analyses of resistance to next-generation aminoglycosides conferred by AAC(2') enzymes.Sci Rep2021https://conductscience.org/library/papers/34078922PubMed
33,288,712Dissociating antibacterial from ototoxic effects of gentamicin C-subtypes.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/33288712PubMed
33,007,139An Advanced Apralog with Increased in vitro and in vivo Activity toward Gram-negative Pathogens and Reduced ex vivo Cochleotoxicity.ChemMedChem2021https://conductscience.org/library/papers/33007139PubMed
32,326,389Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity towards Insulin-Producing β Cells.Antibiotics (Basel)2020https://conductscience.org/library/papers/32326389PubMed
31,790,244Apralogs: Apramycin 5-O-Glycosides and Ethers with Improved Antibacterial Activity and Ribosomal Selectivity and Reduced Susceptibility to the Aminoacyltranserferase (3)-IV Resistance Determinant.J Am Chem Soc2020https://conductscience.org/library/papers/31790244PubMed
31,594,862Functionally critical residues in the aminoglycoside resistance-associated methyltransferase RmtC play distinct roles in 30S substrate recognition.J Biol Chem2019https://conductscience.org/library/papers/31594862PubMed
31,436,080Modification at the 2'-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity.ACS Infect Dis2019https://conductscience.org/library/papers/31436080PubMed
31,303,992Synthesis, ribosomal selectivity, and antibacterial activity of netilmicin 4'-derivatives.Medchemcomm2019https://conductscience.org/library/papers/31303992PubMed
31,057,735Synthesis of saccharocin from apramycin and evaluation of its ribosomal selectivity.Medchemcomm2019https://conductscience.org/library/papers/31057735PubMed
30,793,894
Design, Multigram Synthesis, and in Vitro and in Vivo Evaluation of Propylamycin: A Semisynthetic 4,5-Deoxystreptamine Class Aminoglycoside for the Treatment of Drug-Resistant Enterobacteriaceae and Other Gram-Negative Pathogens.
J Am Chem Soc2019https://conductscience.org/library/papers/30793894PubMed
30,447,062Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation.EcoSal Plus2018https://conductscience.org/library/papers/30447062PubMed

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGA175PubTator's text mininghttps://conductscience.org/library/genes/175NCBI Gene
NAT210PubTator's text mininghttps://conductscience.org/library/genes/10NCBI Gene
SLC25A6293PubTator's text mininghttps://conductscience.org/library/genes/293NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29708331

GET https://conductscience.org/api/papers/v1/29708331/references?page=2